Asia Pacific Immunohistochemistry Market Size, Share & Trends Analysis Report By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Research), By End-use, By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                   1.2. Segment Definitions
                       1.2.1. Product
                       1.2.2. Application
                       1.2.3. End Use
                       1.2.4. Country scope
                       1.2.5. Estimates and forecasts timeline
                   1.3. Research Methodology
                   1.4. Information Procurement
                       1.4.1. Purchased database
                       1.4.2. GVR’s internal database
                       1.4.3. Secondary sources
                       1.4.4. Primary research
                       1.4.5. Details of primary research
                           1.4.5.1. Data for primary interviews in Asia Pacific
                   1.5. Information or Data Analysis
                       1.5.1. Data analysis models
                   1.6. Market Formulation & Validation
                   1.7. Model Details
                       1.7.1. Commodity flow analysis (Model 1)
                       1.7.2. Approach 1: Commodity flow approach
                       1.7.3. Volume price analysis (Model 2)
                       1.7.4. Approach 2: Volume price analysis
                   1.8. List of Secondary Sources
                   1.9. List of Primary Sources
                   1.10. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Application outlook
                       2.2.3. End Use outlook
                       2.2.4. Country outlook
                   2.3. Competitive Insights
Chapter 3. Asia Pacific Immunohistochemistry Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increase in prevalence of chronic diseases
                           3.2.1.2. Growing geriatric population
                           3.2.1.3. Rise in healthcare spending
                           3.2.1.4. Technological advancements
                       3.2.2. Market restraint analysis
                           3.2.2.1. Limitations of standardization with IHC techniques
                           3.2.2.2. High cost of automated IHC instruments
                       3.2.3. Market challenge analysis
                           3.2.3.1. Lack of standardization in IHC technique
                           3.2.3.2. Limited scope for multiple evaluation
                   3.3. Asia Pacific Immunohistochemistry Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
Chapter 4. Asia Pacific Immunohistochemistry Market: Product Estimates & Trend Analysis
                   4.1. Product Market Share, 2023 & 2030
                   4.2. Segment Dashboard
                   4.3. Asia Pacific Immunohistochemistry Market by Product Outlook
                   4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       4.4.1. Antibodies
                           4.4.1.1. Antibodies Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.1.2. Primary Antibodies
                               4.4.1.2.1. Primary Antibodies Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.1.3. Secondary Antibodies
                               4.4.1.3.1. Secondary Antibodies Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.2. Equipment
                           4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.2.2. Slide Staining System
                               4.4.2.2.1. Slide Staining System Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.2.3. Tissue Microarrays
                               4.4.2.3.1. Tissue Microarrays Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.2.4. Tissue Processing Systems
                               4.4.2.4.1. Tissue Processing Systems Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.2.5. Slide Scanners
                               4.4.2.5.1. Slide Scanners Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.2.6. Others
                               4.4.2.6.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.3. Reagents
                           4.4.3.1. Reagents Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.2. Histological Stains
                               4.4.3.2.1. Histological Stains Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.3. Blocking Sera and Reagents
                               4.4.3.3.1. Blocking Sera and Reagents Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.4. Chromogenic Substrates
                               4.4.3.4.1. Chromogenic Substrates Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.5. Fixation Reagents
                               4.4.3.5.1. Fixation Reagents Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.6. Organic Solvents
                               4.4.3.6.1. Organic Solvents Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.7. Proteolytic Enzymes
                               4.4.3.7.1. Proteolytic Enzymes Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.8. Diluents
                               4.4.3.8.1. Diluents Market estimates and forecasts 2018 to 2030 (USD Million)
                           4.4.3.9. Other Reagents
                               4.4.3.9.1. Other reagents Market estimates and forecasts 2018 to 2030 (USD Million)
                       4.4.4. Kits
                           4.4.4.1. Kits Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Asia Pacific Immunohistochemistry Market: Application Estimates & Trend Analysis
                   5.1. Application Market Share, 2023 & 2030
                   5.2. Segment Dashboard
                   5.3. Asia Pacific Immunohistochemistry Market by Application Outlook
                   5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       5.4.1. Diagnostics
                           5.4.1.1. Diagnostics Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.2. Cancer
                               5.4.1.2.1. Cancer Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.3. Infectious Diseases
                               5.4.1.3.1. Infectious Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.4. Cardiovascular Diseases
                               5.4.1.4.1. Cardiovascular Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.5. Autoimmune Diseases
                               5.4.1.5.1. Autoimmune Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.6. Diabetes Mellitus
                               5.4.1.6.1. Diabetes Mellitus Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.7. Nephrological Diseases
                               5.4.1.7.1. Nephrological Diseases Market estimates and forecasts 2018 to 2030 (USD Million)
                           5.4.1.8. Others
                               5.4.1.8.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
                       5.4.2. Research
                           5.4.2.1. Research Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Asia Pacific Immunohistochemistry Market: End Use Estimates & Trend Analysis
                   6.1. End Use Market Share, 2023 & 2030
                   6.2. Segment Dashboard
                   6.3. Asia Pacific Immunohistochemistry Market by End Use Outlook
                   6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.4.1. Hospitals & Diagnostic Laboratories
                           6.4.1.1. Hospitals & Diagnostic Laboratories Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.2. Research Institutes
                           6.4.2.1. Research Institutes Market estimates and forecasts 2018 to 2030 (USD Million)
                       6.4.3. Others
                           6.4.3.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Asia Pacific Immunohistochemistry Market: Country Estimates & Trend Analysis
                   7.1. Country Market Share Analysis, 2023 & 2030
                   7.2. Country Market Dashboard
                   7.3. Country Market Snapshot
                   7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
                   7.5. Japan
                       7.5.1. Key country dynamics
                       7.5.2. Regulatory framework/ reimbursement structure
                       7.5.3. Competitive scenario
                       7.5.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                   7.6. China
                       7.6.1. Key country dynamics
                       7.6.2. Regulatory framework/ reimbursement structure
                       7.6.3. Competitive scenario
                       7.6.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                   7.7. India
                       7.7.1. Key country dynamics
                       7.7.2. Regulatory framework/ reimbursement structure
                       7.7.3. Competitive scenario
                       7.7.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                   7.8. South Korea
                       7.8.1. Key country dynamics
                       7.8.2. Regulatory framework/ reimbursement structure
                       7.8.3. Competitive scenario
                       7.8.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                   7.9. Australia
                       7.9.1. Key country dynamics
                       7.9.2. Regulatory framework/ reimbursement structure
                       7.9.3. Competitive scenario
                       7.9.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                   7.10. Singapore
                       7.10.1. Key country dynamics
                       7.10.2. Regulatory framework/ reimbursement structure
                       7.10.3. Competitive scenario
                       7.10.4. Singapore market estimates and forecasts 2018 to 2030 (USD Million)
                   7.11. Thailand
                       7.11.1. Key country dynamics
                       7.11.2. Regulatory framework/ reimbursement structure
                       7.11.3. Competitive scenario
                       7.11.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                   7.12. Malaysia
                       7.12.1. Key country dynamics
                       7.12.2. Regulatory framework/ reimbursement structure
                       7.12.3. Competitive scenario
                       7.12.4. Malaysia market estimates and forecasts 2018 to 2030 (USD Million)
                   7.13. Indonesia
                       7.13.1. Key country dynamics
                       7.13.2. Regulatory framework/ reimbursement structure
                       7.13.3. Competitive scenario
                       7.13.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
                   7.14. Philippines
                       7.14.1. Key country dynamics
                       7.14.2. Regulatory framework/ reimbursement structure
                       7.14.3. Competitive scenario
                       7.14.4. Philippines market estimates and forecasts 2018 to 2030 (USD Million)
                   7.15. Vietnam
                       7.15.1. Key country dynamics
                       7.15.2. Regulatory framework/ reimbursement structure
                       7.15.3. Competitive scenario
                       7.15.4. Vietnam market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                       8.3.4. Thermo Fisher Scientific Inc.
                           8.3.4.1. Company overview
                           8.3.4.2. Financial performance
                           8.3.4.3. Product benchmarking
                           8.3.4.4. Strategic initiatives
                       8.3.5. F. Hoffmann-La Roche Ltd.
                           8.3.5.1. Company overview
                           8.3.5.2. Financial performance
                           8.3.5.3. Product benchmarking
                           8.3.5.4. Strategic initiatives
                       8.3.6. Merck KGaA
                           8.3.6.1. Company overview
                           8.3.6.2. Financial performance
                           8.3.6.3. Product benchmarking
                           8.3.6.4. Strategic initiatives
                       8.3.7. Danaher Corporation
                           8.3.7.1. Company overview
                           8.3.7.2. Financial performance
                           8.3.7.3. Product benchmarking
                           8.3.7.4. Strategic initiatives
                       8.3.8. PerkinElmer, Inc.
                           8.3.8.1. Company overview
                           8.3.8.2. Financial performance
                           8.3.8.3. Product benchmarking
                           8.3.8.4. Strategic initiatives
                       8.3.9. Bio-Rad Laboratories, Inc.
                           8.3.9.1. Company overview
                           8.3.9.2. Financial performance
                           8.3.9.3. Product benchmarking
                           8.3.9.4. Strategic initiatives
                       8.3.10. Cell Signaling Technology, Inc.
                           8.3.10.1. Company overview
                           8.3.10.2. Financial performance
                           8.3.10.3. Product benchmarking
                           8.3.10.4. Strategic initiatives
                       8.3.11. Bio SB
                           8.3.11.1. Company overview
                           8.3.11.2. Financial performance
                           8.3.11.3. Product benchmarking
                           8.3.11.4. Strategic initiatives
                       8.3.12. Agilent Technologies, Inc.
                           8.3.12.1. Company overview
                           8.3.12.2. Financial performance
                           8.3.12.3. Product benchmarking
                           8.3.12.4. Strategic initiatives
                       8.3.13. Abcam plc.
                           8.3.13.1. Company overview
                           8.3.13.2. Financial performance
                           8.3.13.3. Product benchmarking
                           8.3.13.4. Strategic initiatives
                       8.3.14. HiMedia Laboratories
                           8.3.14.1. Company overview
                           8.3.14.2. Financial performance
                           8.3.14.3. Product benchmarking
                           8.3.14.4. Strategic initiatives
                       8.3.15. IMGENEX INDIA Pvt. Ltd.
                           8.3.15.1. Company overview
                           8.3.15.2. Financial performance
                           8.3.15.3. Product benchmarking
                           8.3.15.4. Strategic initiatives
                       8.3.16. Sino Biological, Inc.
                           8.3.16.1. Company overview
                           8.3.16.2. Financial performance
                           8.3.16.3. Product benchmarking
                           8.3.16.4. Strategic initiatives
                       8.3.17. NICHIREI BIOSCIENCES INC. (NICHIREI CORPORATION)
                           8.3.17.1. Company overview
                           8.3.17.2. Financial performance
                           8.3.17.3. Product benchmarking
                           8.3.17.4. Strategic initiatives
                       8.3.18. MEDICAL ＆ BIOLOGICAL LABORATORIES CO., LTD.
                           8.3.18.1. Company overview
                           8.3.18.2. Financial performance
                           8.3.18.3. Product benchmarking
                           8.3.18.4. Strategic initiatives
                       8.3.19. Immuno-Biological Laboratories Co,Ltd.
                           8.3.19.1. Company overview
                           8.3.19.2. Financial performance
                           8.3.19.3. Product benchmarking
                           8.3.19.4. Strategic initiatives
                       8.3.20. Kyowa Kirin Co., Ltd.
                           8.3.20.1. Company overview
                           8.3.20.2. Financial performance
                           8.3.20.3. Product benchmarking
                           8.3.20.4. Strategic initiatives
                       8.3.21. Amos Scientific PTY. LTD.
                           8.3.21.1. Company overview
                           8.3.21.2. Financial performance
                           8.3.21.3. Product benchmarking
                           8.3.21.4. Strategic initiatives
                       8.3.22. PathnSitu Biotechnologies Pvt Ltd
                           8.3.22.1. Company overview
                           8.3.22.2. Financial performance
                           8.3.22.3. Product benchmarking
                           8.3.22.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Asia Pacific immunohistochemistry market, by country, 2018 - 2030 (USD Million)
Table 3 Asia Pacific immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 4 Asia Pacific immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 5 Asia Pacific immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 6 Japan immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 7 Japan immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 8 Japan immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 9 China immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 10 China immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 11 China immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 12 India immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 13 India immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 14 India immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 15 South Korea immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 16 South Korea immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 17 South Korea immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 18 Australia immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 19 Australia immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 20 Australia immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 21 Thailand immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 22 Thailand immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 23 Thailand immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 24 Singapore immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 25 Singapore immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 26 Singapore immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 27 Malaysia immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 28 Malaysia immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 29 Malaysia immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 30 Indonesia immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 31 Indonesia immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 32 Indonesia immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 33 Philippines immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 34 Philippines immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 35 Philippines immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
Table 36 Vietnam immunohistochemistry market, by product, 2018 - 2030 (USD Million)
Table 37 Vietnam immunohistochemistry market, by application, 2018 - 2030 (USD Million)
Table 38 Vietnam immunohistochemistry market, by end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in APAC
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Asia Pacific immunohistochemistry market: market outlook
Fig. 10 Asia Pacific immunohistochemistry competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Asia Pacific immunohistochemistry market driver impact
Fig. 16 Asia Pacific immunohistochemistry market restraint impact
Fig. 17 Asia Pacific immunohistochemistry market strategic initiatives analysis
Fig. 18 Asia Pacific immunohistochemistry market: Product movement analysis
Fig. 19 Asia Pacific immunohistochemistry market: Product outlook and key takeaways
Fig. 20 Antibodies market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 21 Primary antibodies estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 22 Secondary antibodies market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 23 Equipment estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 24 Slide staining system market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 25 Tissue microarrays market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 26 Tissue processing systems market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 27 Slide scanners market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 28 Others estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 29 Reagents market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 30 Histological stains market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 31 Blocking sera and reagents market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 32 Chromogenic substrates market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 33 Fixation reagents market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 34 Organic solvents market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 35 Proteolytic enzymes market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 36 Diluents market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 37 Other reagents market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 38 Kits estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Fig. 39 Asia Pacific immunohistochemistry Market: Application movement Analysis
Fig. 40 Asia Pacific immunohistochemistry market: Application outlook and key takeaways
Fig. 41 Diagnostics market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 42 Cancer market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 43 Infectious diseases market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 44 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 45 Autoimmune diseases market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 46 Diabetes mellitus market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 47 Nephrological diseases market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 48 Others market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 49 Research market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 50 Asia Pacific immunohistochemistry market: End use movement analysis
Fig. 51 Asia Pacific immunohistochemistry market: End use outlook and key takeaways
Fig. 52 Hospitals and diagnostic laboratories market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 53 Research institutes market estimates and forecasts,2018 - 2030 (Revenue, USD Million)
Fig. 54 Others market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 55 Asia Pacific immunohistochemistry market: Country outlook and key takeaways
Fig. 56 Japan key country dynamics
Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 58 China key country dynamics
Fig. 59 China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 60 India key country dynamics
Fig. 61 India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 62 South Korea key country dynamics
Fig. 63 South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 64 Australia key country dynamics
Fig. 65 Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 66 Singapore key country dynamics
Fig. 67 Singapore market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 68 Thailand key country dynamics
Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 70 Malaysia key country dynamics
Fig. 71 Malaysia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 72 Indonesia key country dynamics
Fig. 73 Indonesia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 74 Philippines key country dynamics
Fig. 75 Philippines market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 76 Vietnam key country dynamics
Fig. 77 Vietnam market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Fig. 78 Market share of key market players - Asia Pacific immunohistochemistry market, 2023